A Retrospective Review of Metastatic or Recurrent Uterine Sarcomas Treated with Ifosfamide and Doxorubicin (IMA)

AKSOY, SERCAN; Hizli, Deniz; Sarici, Saynur; Oecalan, Reyhan; Koese, Mehmet; Gueler, Niluefer

A Retrospective Review of Metastatic or Recurrent Uterine Sarcomas Treated with Ifosfamide and Doxorubicin (IMA)

Copy For Citation

AKSOY S., Hizli D., Sarici S., Oecalan R., Koese M. F. , Gueler N.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, vol.18, no.3, pp.129-134, 2008 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 18 Issue: 3
Publication Date: 2008
Title of Journal : UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
Page Numbers: pp.129-134

Abstract

The prognosis of metastatic uterine sarcoma is poor with median survival reported between 4 to 26 months. We evaluated the efficacy and toxicity of ifosfamide (1), mesna (M) and doxorubicin (A) (IMA) chemotherapy regimen retrospectively in patients with metastatic or recurrent uterine sarcomas.